Pharmaids Pharmaceuticals Limited (BOM:524572)

India flag India · Delayed Price · Currency is INR
39.87
+0.92 (2.36%)
At close: Feb 12, 2026
Market Cap1.34B -48.0%
Revenue (ttm)248.12M -1.1%
Net Income-132.67M
EPS-3.52
Shares Out35.27M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,104
Average Volume4,309
Open39.99
Previous Close38.95
Day's Range37.31 - 40.00
52-Week Range37.11 - 75.98
Beta0.06
RSI38.60
Earnings DateFeb 12, 2026

About Pharmaids Pharmaceuticals

Pharmaids Pharmaceuticals Limited, together with its subsidiaries, provides contract research and manufacturing services for pharma, biotech, agro, and chemical industries in India. The company offers pharma intermediates, such as Dichloro Benzoyl nitrile, hydrazine carboximidamide 2 methane, pyridine carbonitrile,pyridine carboxylic acid, 8-chloro-10, 11-dihydro-4-aza-5H-dibenzo cycloheptene-5-one, 8-chloro-6,11-dihydro-11 cyclohepta pyridine,2-amino-5-methylthiopene-3-carbonitrile, 5-methyl-2-amino]thiophene-3-carbonitrile, 4-amino-2-methyl-1... [Read more]

Industry Pharmaceutical Preparations
Founded 1989
Employees 28
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524572
Full Company Profile

Financial Performance

In fiscal year 2025, Pharmaids Pharmaceuticals's revenue was 195.14 million, an increase of 27.54% compared to the previous year's 153.00 million. Losses were -107.77 million, 35.2% more than in 2024.

Financial Statements